WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark was filed as Figurative mark on 01/03/2018 at the World Intellectual Property Organization.

Logodesign (Wiener Klassifikation)

#Other polygons #Colours #One polygon #Polygons containing one or more triangles or lines forming an angle (specify the content) #Polygons containing one or more other geometrical figures (specify the content) #Two predominant colours

Trademark Details Last update: February 12, 2021

Trademark form Figurative mark
File reference 1408354
Countries Australia China European Community United Kingdom Japan
Base trademark US No. 87565885, August 11, 2017
Application date January 3, 2018
Expiration date January 3, 2028

Trademark owner

8717 W 110th Street, Suite 300
Overland Park KS 66210
US

Trademark representatives

10801 Mastin Blvd., Suite 1000 Overland Park KS 66210 US

goods and services

35 Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files; business consulting services in the medical, pharmaceutical, and biotechnology fields
42 Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes; consulting services in the biotechnology field
44 Consulting services in the medical and pharmaceutical fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status
45 Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; regulatory compliance consulting in the fields of drug and device development and manufacturing; tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Trademark history

Date Document number Area Entry
January 27, 2021 2021/6 Gaz RAW: Holder Rights Restriction
March 14, 2019 2019/27 Gaz JP Rejection
February 27, 2019 2019/10 Gaz CN Rejection
February 19, 2019 2019/27 Gaz AU Rejection
February 6, 2019 2019/6 Gaz GB RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 15, 2019 2019/7 Gaz CN Rejection
November 23, 2018 2018/49 Gaz EM Rejection
July 27, 2018 2018/32 Gaz GB Rejection
January 3, 2018 US Registration

ID: 141408354